Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity

19Citations
Citations of this article
165Readers
Mendeley users who have this article in their library.

Abstract

Recent advances in synthetic biology and biological system engineering have allowed the design and construction of engineered live biotherapeutics targeting a range of human clinical applications. In this review, we outline how systems approaches have been used to move from simple constitutive systems, where a single therapeutic molecule is expressed, to systems that incorporate sensing of the in vivo environment, feedback, computation, and biocontainment. We outline examples where each of these capabilities are achieved in different human disorders, including cancer, inflammation, and metabolic disease, in a number of environments, including the gastrointestinal tract, the liver, and the oral cavity. Throughout we highlight the challenges of developing microbial therapeutics that are both sensitive and specific. Finally, we discuss how these systems are leading to the realization of engineered live biotherapeutics in the clinic.

Cite

CITATION STYLE

APA

Ozdemir, T., Fedorec, A. J. H., Danino, T., & Barnes, C. P. (2018, July 25). Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity. Cell Systems. Cell Press. https://doi.org/10.1016/j.cels.2018.06.008

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free